Clinical trial
Evaluation of Combined Fine-needle Diathermy and Subconjunctival Bevacizumab Injection in the Treatment of Corneal Neovascularization
NCT07642960 is registered in ClinicalTrials.gov with HoChiMinh City Eye Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Combined Fine-needle Diathermy and Subconjunctival Bevacizumab Injection in the Treatment of Corneal Neovascularization
- Lead sponsor
- HoChiMinh City Eye Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 1, 2026
- Completion date
- April 1, 2028
- Enrollment
- 51 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
corneal neovascularisation